01/06/2023 3:19 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2023 3:45 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2022 12:24 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2022 3:11 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/28/2022 3:10 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2022 5:49 PM | Dier Mardi (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
10/14/2022 11:58 AM | Dier Mardi (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2022 8:39 PM | Dier Mardi (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/15/2022 3:07 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/08/2022 5:36 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2022 3:12 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/14/2022 7:36 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/29/2022 2:48 PM | Sanders Corazon D. (0001796536) (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2022 12:50 PM | Ray Amrit (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2022 12:51 PM | NARACHI MICHAEL (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2022 12:52 PM | Fust Matthew K (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2022 12:53 PM | Ekman Lars (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2022 12:54 PM | Ultragenyx Pharmaceutical (Issuer) WELCH DANIEL G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2022 12:48 PM | Dunsire Deborah (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2022 12:48 PM | SULIMAN SHEHNAAZ (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2022 3:12 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/22/2022 6:27 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2022 7:06 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/05/2022 3:01 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/22/2022 11:30 AM | Ray Amrit (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/22/2022 11:31 AM | Ray Amrit (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2022 7:05 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/19/2022 11:56 AM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/09/2021 5:22 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/02/2021 5:11 PM | Bedrosian Camille L (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/08/2021 10:56 AM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2021 7:46 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2021 5:22 PM | SULIMAN SHEHNAAZ (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2021 5:23 PM | NARACHI MICHAEL (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2021 5:24 PM | Fust Matthew K (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2021 5:24 PM | Ekman Lars (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2021 5:25 PM | Dunsire Deborah (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2021 5:26 PM | Aliski William (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2021 5:27 PM | Ultragenyx Pharmaceutical (Issuer) WELCH DANIEL G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2021 8:00 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
06/23/2021 4:55 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2021 8:08 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2021 7:35 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/19/2021 7:46 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2021 7:46 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2021 5:14 PM | Huang Dennis Karl (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2021 5:09 PM | Bedrosian Camille L (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2021 5:10 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2021 5:11 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2021 5:11 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2021 5:12 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2021 5:13 PM | Pinion John Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2021 5:13 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2021 3:46 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/05/2021 10:32 AM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/21/2021 7:07 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2021 4:16 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2021 4:17 PM | Bedrosian Camille L (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2021 5:03 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/09/2021 11:37 AM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:55 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:38 PM | Dier Mardi (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:39 PM | Huang Dennis Karl (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:42 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:43 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:47 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:48 PM | Pinion John Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:36 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 7:37 PM | Bedrosian Camille L (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2021 1:30 PM | Aliski William (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/03/2021 7:01 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/03/2021 7:02 PM | Aliski William (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/03/2021 7:03 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 5 Annual statement of changes in beneficial ownership of securities | |
02/03/2021 7:04 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2021 3:28 PM | Bedrosian Camille L (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/21/2021 7:46 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/19/2021 3:01 PM | Bedrosian Camille L (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2021 6:15 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2021 6:05 PM | Huizenga Theodore Alan (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2021 8:16 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2021 5:45 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2020 3:15 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/10/2020 3:55 PM | Arcturus Therapeutics Holdings Inc. (Issuer) Ultragenyx Pharmaceutical (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2020 5:04 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2020 2:44 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2020 4:05 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2020 3:05 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2020 4:26 PM | Solid Biosciences Inc. (Issuer) Ultragenyx Pharmaceutical (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/30/2020 4:28 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/27/2020 3:20 PM | Ultragenyx Pharmaceutical (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
|
10/27/2020 3:07 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/26/2020 3:11 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/23/2020 7:16 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2020 6:18 PM | Huang Dennis Karl (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2020 6:19 PM | Pinion John Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2020 6:20 PM | Harris Erik (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2020 6:20 PM | Kassberg Thomas Richard (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2020 6:21 PM | Parschauer Karah Herdman (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2020 6:22 PM | Bedrosian Camille L (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2020 6:23 PM | KAKKIS EMIL D (Reporting) Ultragenyx Pharmaceutical (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |